Jack Stoch
Chief Executive Officer presso GLOBEX MINING ENTERPRISES INC.
Patrimonio netto: 3 M $ in data 31/03/2024
Provenienza dei contatti di primo grado di Jack Stoch
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Precious Metals | 10 | |
Sir George Williams University
9
| College/University | Other Consumer Services | 9 |
Public Company | Precious Metals | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jack Stoch tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
PINETREE CAPITAL LTD. | Financial Conglomerates | Director of Finance/CFO | |
PTX METALS INC. | Precious Metals | Director of Finance/CFO | |
SABRE GOLD MINES CORP. | Precious Metals | Director of Finance/CFO | |
GOSSAN RESOURCES LIMITED | Precious Metals | Director/Board Member Director of Finance/CFO | |
ROYAL STANDARD MINERALS INC. | Precious Metals | Chief Executive Officer | |
TINTINA MINES LIMITED | Other Metals/Minerals | Director/Board Member | |
COPPER ROAD RESOURCES INC. | Precious Metals | Director of Finance/CFO | |
DYNACERT INC. | Trucks/Construction/Farm Machinery | Director of Finance/CFO | |
GOLD X MINING CORP. | Precious Metals | Director/Board Member Director of Finance/CFO | |
INVENTUS MINING CORP. | Precious Metals | Director of Finance/CFO | |
SINTANA ENERGY INC | Contract Drilling | Director of Finance/CFO | |
Trelawney Augen Acquisition Corp.
Trelawney Augen Acquisition Corp. Precious MetalsNon-Energy Minerals Trelawney Augen Acquisition Corp. explores gold and mineral properties. The company was founded in 2006 and is headquartered in Toronto, Canada. | Precious Metals | Director of Finance/CFO | |
BE RESOURCES INC. | Other Metals/Minerals | Chief Executive Officer Director of Finance/CFO | |
HANNA CAPITAL CORP. | Other Metals/Minerals | Director of Finance/CFO | |
G2 GOLDFIELDS INC. | Precious Metals | Director of Finance/CFO Director of Finance/CFO | |
GPM METALS INC. | Other Metals/Minerals | Director of Finance/CFO | |
Concordia University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin | |
University of Ottawa | College/University | Undergraduate Degree Masters Business Admin | |
University of Toronto | College/University | Undergraduate Degree | |
McMaster University | College/University | Masters Business Admin Undergraduate Degree | |
MEGA URANIUM LTD. | Other Metals/Minerals | Director of Finance/CFO | |
OUTDOORPARTNER MEDIA CORPORATION | Advertising/Marketing Services | Director/Board Member | |
Institute of Chartered Secretaries & Administrators of Canada | Corporate Officer/Principal Corporate Officer/Principal | ||
Marrelli & Drake Corporate Services | Corporate Officer/Principal | ||
REVIVAL GOLD INC. | Precious Metals | Director of Finance/CFO | |
Waverley Resources Ltd.
Waverley Resources Ltd. Precious MetalsNon-Energy Minerals Waverley Resources Ltd. is an exploration stage company, which engages in the acquisition of gold mining properties. The company was founded on February 12, 2007 and is headquartered in Toronto, Canada. | Precious Metals | Director of Finance/CFO | |
DSA Corporate Services, Inc. | Director/Board Member Corporate Officer/Principal | ||
MARTINA MINERALS CORP. | Precious Metals | Director of Finance/CFO | |
NEW FRONTIER VENTURES INC. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Revive Therapeutics, Inc.
Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The private company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Pharmaceuticals: Major | Director of Finance/CFO | |
REVIVE THERAPEUTICS LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
HYLANDS INTERNATIONAL HOLDINGS INC. | Other Metals/Minerals | Director/Board Member Director/Board Member | |
AYR WELLNESS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
OLIVE RESOURCE CAPITAL INC. | Precious Metals | Director of Finance/CFO | |
SKYLIGHT HEALTH GROUP INC. | Medical/Nursing Services | Director of Finance/CFO | |
SINTANA ENERGY INC. | Director of Finance/CFO | ||
BLUE LAGOON RESOURCES INC. | Other Metals/Minerals | Director of Finance/CFO | |
ARANJIN RES | Other Metals/Minerals | Director of Finance/CFO | |
PHIVIDA HOLDINGS INC. | Pharmaceuticals: Other | Director of Finance/CFO |
Statistiche
Distribuzione geografica
Canada | 47 |
Stati Uniti | 3 |
Settori
Non-Energy Minerals | 27 |
Finance | 7 |
Consumer Services | 5 |
Health Technology | 5 |
Commercial Services | 3 |
Posizioni
Director of Finance/CFO | 98 |
Director/Board Member | 84 |
Corporate Officer/Principal | 70 |
Independent Dir/Board Member | 31 |
Chairman | 30 |
Contatti più connessi
Insiders | |
---|---|
Carmelo Marrelli | 105 |
Donald Wright | 52 |
Ian Atkinson | 26 |
Joel D. Schneyer | 20 |
William McGuinty | 14 |
Marie-Josée Audet | 10 |
David Lotan | 9 |
Christopher Neuman | 8 |
Allan H. Shapiro | 8 |
Andrew Newbury | 8 |
Johannes van Hoof | 8 |
Wayne Edward Deans | 8 |
James G. Wilson | 7 |
Rimant V. Zalnieriunas | 7 |
Chris Bryan | 7 |
- Borsa valori
- Insiders
- Jack Stoch
- Connessioni Società